Compare Tencent Music Entertainment Group - ADR (TME) vs Travere Therapeutics Inc. Common Stock (TVTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tencent Music Entertainment Group - ADR vs Travere Therapeutics Inc. Common Stock — how do they compare? Tencent Music Entertainment Group - ADR trades at $8.32 (market cap $13.81B), while Travere Therapeutics Inc. Common Stock trades at $52.74 (market cap $4.88B). The key difference: Tencent Music Entertainment Group - ADR is far larger — about 2.8× Travere Therapeutics Inc. Common Stock's market cap, and Tencent Music Entertainment Group - ADR pays a 2.82% dividend while Travere Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tencent Music Entertainment Group - ADR for 68 Days and Travere Therapeutics Inc. Common Stock for 0 Days on average.
| TME | TVTX | |
|---|---|---|
Market Cap | $13.81B | $4.88B |
Volume | 6,097,902 | 1,668,577 |
Sector | Media | Health |
52-Week High | $23.71 | $67.52 |
52-Week Low | $7.74 | $26.79 |
Typical Hold Time | 68 Days | 0 Days |
Enterprise Value | $11.76B | $5.01B |
Dividend Yield | 2.82% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tencent Music Entertainment (TME) trades at $8.48, up 0.36% on the day, with a bullish technical signal and strong fundamentals. Revenue grew to $32.9B in 2025, with net income surging to $11.06B, and valuation ratios like a P/E of 9.94 appear attractive. Recent news highlights a $1B notes offering and a $400M share repurchase program, signaling financial discipline.
The outlook is positive with a consensus price target of $12.50, offering 47% upside, but risks include intense competition and regulatory oversight. Earnings have been mixed, with Q2 2026 beating expectations but Q1 and Q4 2025 missing, indicating potential volatility in performance.
Travere Therapeutics (TVTX) trades at $51.80, down 0.42% on the day, with a neutral technical signal. The company reported strong revenue growth but persistent net losses, with a 2025 net income margin of -7.35%. Recent news includes new data presentations for its key drug FILSPARI and a CEO transition. Analyst consensus is strongly bullish with an 83.33% buy rating and a $70.60 price target, suggesting significant upside from the current price.
The outlook for TVTX hinges on the commercial success of FILSPARI, which shows promising sales growth, but profitability remains a challenge. Key risks include execution of the CEO transition, competitive pressures in nephrology treatments, and the company's ability to achieve sustained profitability. The high valuation multiples relative to negative earnings present a risk-reward balance for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tencent Music Entertainment Group - ADR
TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →About Travere Therapeutics Inc. Common Stock
Travere Therapeutics Inc. is a biopharmaceutical company focused on rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an oral medication for adults with IgA nephropathy, and it also markets Thiola for cystinuria.
Read more on TVTX →
